Richard K Adler, PHD CCC SLP in Moorhead, MN - Speech-Language Pathologist

Richard K Adler, PHD CCC SLP is a Speech-language Pathologist based in Moorhead, Minnesota. Richard K Adler is licensed to practice in Minnesota (license number 7534) and his current practice location is 1104 7th Ave South, Moorhead, Minnesota. He can be reached at his office (for appointments etc.) via phone at (218) 477-5841.

NPI number for Richard K Adler is 1336231943 and his current mailing address is 1104 7th Ave South, Msum Box 119, Moorhead, Minnesota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1336231943.

Contact Information

	Richard K Adler, PHD CCC SLP
	1104 7th Ave South, Moorhead, MN 56563-0001
	(218) 477-5841
	(218) 477-4392

Healthcare Provider's Profile

Full Name	Richard K Adler
Gender	Male
Speciality	Speech-language Pathologist
Location	1104 7th Ave South, Moorhead, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1336231943
Provider Enumeration Date: 09/29/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Richard K Adler such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1336231943	NPI	-	NPPES
434S2AD	Other	MN	MN BCBS
22578	Other	ND	ND BCBS
54170	Medicaid	ND

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	7534 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Richard K Adler is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Richard K Adler, PHD CCC SLP 1104 7th Ave South, Msum Box 119, Moorhead, MN 56563-0001 Ph: (218) 477-5841	Richard K Adler, PHD CCC SLP 1104 7th Ave South, Moorhead, MN 56563-0001 Ph: (218) 477-5841

News Archive

FDA approves Novartis' Zortress to prevent organ rejection after liver transplantation in adults

Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant.

Study finds clustered cardiometabolic risk factors in children

Lifestyle-related cardiometabolic risk factors cluster already in children in the same way as in adults, according to research from the University of Eastern Finland. A cardiometabolic risk score was used to evaluate cardiometabolic risk in different age groups.

More than 60% of fire ant allergic patients do not adhere to treatment guidelines

Two million Americans are allergic to insect stings, an allergy which sends more than 500,000 people to the emergency room annually. Yet, according to a study published today in the March issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAA), while fire ant allergy sufferers know allergy shots can save their life, more than 60 percent do not adhere to treatment guidelines.

Venous thromboembolism drugs to experience robust growth by 2019

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven primarily by the launch and widespread uptake of novel oral anticoagulants, the combined markets for drugs used in the treatment and prophylaxis of venous thromboembolism will experience robust growth, increasing from $2.9 billion in 2009 to more than $5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

Merck returns worldwide development and commercialization rights for AN2690 to Anacor Pharmaceuticals

Anacor Pharmaceuticals announced today that Merck has returned full worldwide development and commercialization rights for AN2690 to Anacor. AN2690 is a topical anti-fungal therapy being developed for onychomycosis, a fungal infection of the nail and nail bed. It is estimated that onychomycosis affects approximately 35 million people in the United States.

Speech-Language Pathologist in Moorhead, MN

Vicki L Riedinger, MS CCC SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1104 7th Ave South, Msum Box 119, Moorhead, MN 56563 Phone: 218-477-4627 Fax: 218-477-4392
Larae A Mcgillivray, MS CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1104 7th Ave S, Msum Box 119, Moorhead, MN 56563 Phone: 218-477-4639 Fax: 218-477-4392
Louis J Demaio, PHD CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1104 7th Ave South, Msum Box 119, Moorhead, MN 56563 Phone: 218-477-4643 Fax: 218-477-4392
Bruce R Hanson, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1104 7th Ave South, Msum Box 119, Moorhead, MN 56563 Phone: 218-477-4641 Fax: 218-477-4392
Mr. Lowell Matthew Buysse, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1104 7th Ave South, Murray Hall, Moorhead, MN 56563 Phone: 218-477-2330 Fax: 218-477-4392
Marie E Swanson, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1104 7th Ave South, Msum Box 119, Moorhead, MN 56563 Phone: 218-477-5841 Fax: 218-477-4392
Nancy A Paul, MS CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1104 7th Ave S, Msum Box 119, Moorhead, MN 56563 Phone: 218-477-4642 Fax: 218-477-4392

Richard K Adler, PHD CCC SLP - Speech-Language Pathologist in Moorhead, MN